This obituary talks about a man named Stephen Crohn, who had a rare genetic mutation that made him immune to the AIDS virus. The connection to gene patenting and patenting in general came in when the Diamond Center received a patent to test people for this genetic mutation. Even though the Diamond Center received a patent for this test, Stephen Crohn did not receive any compensation for volunteering himself for these tests. Therefore, this news brings up the question as to whether or not companies that patent genes focused on rare mutations should be required to give compensation to the human subjects. Additionally, in reference to the papers we read for class today, it seems clear that this "genetic test" is not something naturally occurring in nature; therefore, it is reasonable that it was given a patent.